Impilo
Impilo Ab is a private equity firm established in 2017 and headquartered in Stockholm, Sweden, with an additional office in Copenhagen, Denmark. The firm specializes in buyout and growth capital investments within the healthcare sector, focusing on pharmaceutical, medical technology, healthcare services, and other health-related industries. Impilo aims to invest in companies based in the Nordic region, with a typical investment range of SEK 100 million to SEK 1000 million in firms generating revenues between SEK 200 million and SEK 1.5 billion. While primarily targeting majority stakes, the firm may also consider minority investments. Impilo emphasizes the importance of contributing to positive and sustainable development in the communities and markets where its portfolio companies operate, reflecting a commitment to long-term success.
Scantox is a contract research organization that specializing in pharmacology and regulatory toxicology services. Their preclinical contract research services enable clients to progress their drug or device development. They offer various contract research services such as safety pharmacology, exploratory, and endotoxin testing.
Cavidi is Sweden’s leading supplier of viral load for HIV monitoring. Cavidi’s products enable efficient management of anti-HIV drugs (ARV therapy) so that people living with HIV can live a normal lifespan. Cavidi’s diagnostics reduce the cost of treatment and the spread of HIV. Cavidi also provides tools and kits for virus research to many of the world’s leading labs. Cavidi is a Swedish biotech company founded as a spin-off from Uppsala University. Their expertise is based on understanding viruses and using this knowledge to create research tools and clinical diagnostics. Today their focus is on HIV but our methods and expertise can be applied to other viruses. Cavidi’s head office is in Uppsala, Sweden and they have sales offices in South Africa, India and USA. Their customers include hospitals, patient clinics, private laboratories, the pharmaceutical industry and research institutions worldwide.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.